DEVELOPMENT OF RESPIRATORY VIRUS INFECTION STRATEGIES FOR RHESUS MACAQUE AIRWAYS

恒河猴呼吸道呼吸道病毒感染策略的制定

• 批准号: 8172568
• 负责人: LISA M MILLER
• 金额: $ 3.8万
• 依托单位: UNIVERSITY OF CALIFORNIA AT DAVIS
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-06-01 至 2011-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8172568
• 关键词: Animal Model; Asthma; Cells; Child; Chronic; Clinical; Computer Retrieval of Information on Scientific Projects Database; Development; Etiology; Experimental Animal Model; Funding; Goals; Grant; Human; Human respiratory syncytial virus; Immune; Immune system; In Vitro; Infection; Institution; Lung; Macaca mulatta; Modeling; Monkeys; Physiological; Predisposition; Primates; Research; Research Personnel; Resources; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Rhinovirus; Rodent Model; Role; Source; Symptoms; United States National Institutes of Health; Vaccines; Viral; airway inflammation; in vivo; postnatal; prevent; respiratory infection virus; respiratory virus

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Our primary objective is to understand the pathogenic role of respiratory virus infection in the etiology of asthma and exacerbation of chronic airways inflammation in humans. Our secondary objective is to develop effective and safe vaccine approaches to prevent respiratory syncytial virus infection in young children. We propose that basic immune and physiologic mechanisms for respiratory virus pathobiology in the lung can only be elucidated using an in vivo animal model of infection. Although rodent models have been developed for respiratory virus infection, this species does not effectively duplicate the postnatal development of both lung and immune systems in primates. Our goal is to develop an experimental animal model of human respiratory syncytial virus and human rhinovirus infection using the rhesus macaque monkey (Macaca mulatta). Towards this end, the first step is to optimize the susceptibility of rhesus monkeys to human respiratory virus infection. We hypothesize that the development of a respiratory infection model that demonstrates human clinical symptoms will require in vitro passaging of human viral isolates in rhesus cells to obtain robust viral replication in monkey airways.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 我们的主要目的是了解呼吸道病毒感染在人类炎症的病因和加剧的病因中的致病作用。我们的次要目标是开发有效且安全的疫苗方法，以防止幼儿的呼吸道合胞病毒感染。我们建议只有使用体内动物的感染模型才能阐明肺中呼吸病毒病理学的基本免疫和生理机制。尽管已经开发出用于呼吸道病毒感染的啮齿动物模型，但该物种并未有效地复制灵长类动物中肺和免疫系统的产后发育。我们的目标是使用恒河猴（Macaca Mulatta）开发人类呼吸道合胞病毒和人类鼻病毒感染的实验动物模型。为此，第一步是优化恒河猴对人呼吸道病毒感染的敏感性。我们假设，证明人类临床症状的呼吸道感染模型的发展将需要在恒河-细胞中的人类病毒分离株进行体外传播，以在猴子气道中获得可靠的病毒复制。